Cargando…

The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been approved for clinical use. SARS-CoV-2 neutralizing antibody titers after immunization are widely used as an evaluation indicator, and the roles of cellular immune responses in the protective efficacy of vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhongjie, Wu, Tingxin, Xie, Huangfan, Li, Yuhuan, Zhang, Jinlan, Su, Xuncheng, Qi, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324880/ https://www.ncbi.nlm.nih.gov/pubmed/35891267 http://dx.doi.org/10.3390/vaccines10071103

Ejemplares similares

Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19
por: Qi, Hailong, et al.
Publicado: (2022)

Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement
por: Sun, Zhongjie, et al.
Publicado: (2022)

Transient Inhibition of the JNK Pathway Promotes Human Hematopoietic Stem Cell Quiescence and Engraftment
por: Xie, Huangfan, et al.
Publicado: (2022)

Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study
por: Cai, Jianqiang, et al.
Publicado: (2021)

A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer
por: Shimizu, Kanako, et al.
Publicado: (2022)

Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination
por: Primorac, Dragan, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response
por: Wang, Xiaolei, et al.
Publicado: (2023)

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
por: Liu, Jinyan, et al.
Publicado: (2022)

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
por: Sui, Yongjun, et al.
Publicado: (2021)

Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
por: Elder, Elizabeth, et al.
Publicado: (2023)

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
por: Homma, Tomoyuki, et al.
Publicado: (2022)

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination
por: Hollstein, Moritz M., et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Humeral and cellular immune responses to SARS-CoV-2 vaccination in patients on peritoneal dialysis
por: Yu, Zhi-Ye, et al.
Publicado: (2023)

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
por: Vasileiou, Spyridoula, et al.
Publicado: (2022)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
por: Qu, Qiaoqiao, et al.
Publicado: (2022)

Persistent Cellular Immunity to SARS-CoV-2 Infection
por: Breton, Gaëlle, et al.
Publicado: (2020)

Persistent cellular immunity to SARS-CoV-2 infection
por: Breton, Gaëlle, et al.
Publicado: (2021)

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
por: McCafferty, Sean, et al.
Publicado: (2022)

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
por: Mairhofer, Mario, et al.
Publicado: (2021)

Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
por: Liu, Jinyan, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
por: Pušnik, Jernej, et al.
Publicado: (2023)

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
por: Favresse, Julien, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults
por: Xiao, Chanchan, et al.
Publicado: (2023)

Humoral and Cellular Immune Response to Sars-Cov-2 Vaccination in Patients with Chronic GVHD
por: Manjappa, Shivaprasad, et al.
Publicado: (2022)

Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection
por: Shrestha, Rupendra, et al.
Publicado: (2021)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
por: Zhang, Jialu, et al.
Publicado: (2021)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
por: Chai, Kit Man, et al.
Publicado: (2021)

A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
por: Bellier, Bertrand, et al.
Publicado: (2022)

Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection
por: Franchi, Matteo, et al.
Publicado: (2023)

Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
por: Vogrig, Manon, et al.
Publicado: (2022)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Cellular immune states in SARS-CoV-2-induced disease
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c1g6v4mg3c8pg0otaar2vcr85o